ANALYSIS: As Vital Healthcare revives a restructuring scheme, directors of its external manager seem particularly antsy about their independence.
The software company has given its bullish investors some pause for thought this year.
The fintech’s float is taking advantage of Australia’s greater enthusiasm for growth companies.
Early indications point to an organised gang or an inside job.
They may be locked in legal battle but Glenn and Watson have something in common.
On past form, the alternative to takeover does not look attractive.
The milk processor is staying on message despite the market's misgivings.
Political intervention in smelter closure speaks volumes about regulator’s performance.
The company’s chair Kim Ellis has made the right call on a takeover scheme.
Compulsory risk disclosure is a cost with vague benefits.
